Evelo Biosciences
(OTC) EVLO
Evelo Biosciences Financials at a Glance
Market Cap
$1.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$82.35M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-27.09 (Low)
Dividend
$0.00
Beta (Volatility)
-27.09 (Low)
Price
$0.00
Volume
22
Open
$0.00
Price
$0.00
Volume
22
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
-27.09 (Low)
Price
$0.00
Volume
22
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
Aug 10, 2026
EVLO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Evelo Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
66
CEO
Simba Gill, PhD, MBA
Website
www.evelobio.comHeadquarters
Cambridge, MA 02139, US
EVLO Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-6232.76%
Return on Capital
-235.05%
Return on Assets
-177.72%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
18.98M
Volume
22
Avg. Volume
611.484
Financials (TTM)
Gross Profit
-$2.41M
Operating Income
-$76.74M
EBITDA
-$74.40M
Operating Cash Flow
-$73.70M
Capital Expenditure
-$287.00K
Free Cash Flow
-$73.99M
Cash & ST Invst.
$17.26M
Total Debt
$33.95M
Evelo Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$793.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$28.79
N/A
Employees
66
N/A
Net Income
-$12.36M
+59.5%
EBITDA
-$11.05M
+62.0%
Quarterly Fundamentals
Total Cash
$17.26M
-75.0%
Total Debt
$33.95M
-38.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$33.95M
+135.0%
Return on Assets
-1.78%
N/A
Return on Invested Capital
-2.08%
N/A
Free Cash Flow
-$10.46M
+53.7%
Operating Cash Flow
-$10.41M
+53.9%